Open access
Open access
Powered by Google Translator Translator

Oncology – Brain

M-A: Stereotactic radiosurgery vs. whole brain radiotherapy in patients with intracranial metastatic disease and small-cell lung cancer.

30 May, 2022 | 10:41h | UTC

Stereotactic radiosurgery versus whole brain radiotherapy in patients with intracranial metastatic disease and small-cell lung cancer: a systematic review and meta-analysis – The Lancet Oncology (link to abstract – $ for full-text)

News Release: Meta-Analysis Shows Targeted Radiation Therapy May Be as Effective as Standard Care for Small Cell Lung Cancer Patients with Brain Metastases – St. Michael’s Hospital

 


Cohort Study: Effect of awake craniotomy in glioblastoma in eloquent areas.

23 May, 2022 | 00:40h | UTC

Effect of awake craniotomy in glioblastoma in eloquent areas (GLIOMAP): a propensity score-matched analysis of an international, multicentre, cohort study – the Lancet Oncology (link to abstract – $ for full-text)

Commentary: Neurologic and Survival Outcomes After Awake Craniotomy for Glioblastoma – The ASCO Post

 

Commentary on Twitter

 


RCT: Treatment with Etirinotecan pegol for patients with metastatic breast cancer and brain metastases.

13 May, 2022 | 10:51h | UTC

Treatment With Etirinotecan Pegol for Patients With Metastatic Breast Cancer and Brain Metastases: Final Results From the Phase 3 ATTAIN Randomized Clinical Trial – JAMA Oncology (free for a limited period)

 

Commentary on Twitter

 


ASTRO Guideline: Radiation therapy for brain metastases.

12 May, 2022 | 10:11h | UTC

Radiation Therapy for Brain Metastases: An ASTRO Clinical Practice Guideline – Practical Radiation Oncology

News Release: ASTRO issues clinical guideline on radiation therapy for brain metastases – American Society for Radiation Oncology

 

Commentary on Twitter

 


Study finds no increased risk of brain tumors for mobile phone users.

1 Apr, 2022 | 10:04h | UTC

News Release: No increased risk of brain tumours for mobile phone users, new study finds – University of Oxford

Original Study: Cellular Telephone Use and the Risk of Brain Tumors: Update of the UK Million Women Study – JNCI: Journal of the National Cancer Institute

 


SEOM-GEINO clinical guideline of systemic therapy and management of brain central nervous system metastases.

18 Mar, 2022 | 08:14h | UTC

SEOM-GEINO clinical guideline of systemic therapy and management of brain central nervous system metastases (2021) – Clinical and Translational Oncology

 


Same-day discharge after brain tumor resection: a prospective pilot study.

9 Mar, 2022 | 08:19h | UTC

Same-day discharge after brain tumor resection: a prospective pilot study – Journal of Neuro-Oncology

 

Commentary on Twitter

 


Systematic Review: Diagnostic test accuracy and cost‐effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.

8 Mar, 2022 | 08:24h | UTC

Diagnostic test accuracy and cost‐effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma – Cochrane Library

 


ASCO-SNO Guideline: Therapy for diffuse astrocytic and oligodendroglial tumors in adults.

26 Jan, 2022 | 01:19h | UTC

Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline – Journal of Clinical Oncology

 


Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline.

21 Jan, 2022 | 09:36h | UTC

Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline – Journal of Clinical Oncology

Related: EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumors.

 


Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab.

16 Nov, 2021 | 08:14h | UTC

Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label, multicentre, phase 2 study – The Lancet Oncology (link to abstract – $ for full-text)

Commentary: Combination immunotherapy improves survival for patients with asymptomatic melanoma brain metastases – The University of Texas MD Anderson Cancer Center

Original Study: Study: Combination Immunotherapy for Melanoma Brain Metastases

Related: #ESMO19 – Randomized Trial: Improved Overall Survival at 5 Years with Combined Immunotherapy for Advanced Melanoma

 


M-A: Treatment options for progression or recurrence of glioblastoma.

26 Sep, 2021 | 21:34h | UTC

Treatment options for progression or recurrence of glioblastoma: a network meta‐analysis – Cochrane Library

Summary: Treatment options for people with recurrent and progressive glioblastoma – Cochrane Library

 


Brain and other central nervous system tumor statistics, 2021 – There were few improvements in the care of Glioblastoma in the past 4 decades. Specifically, the 5-year survival only increased from 4% to 7%.

1 Sep, 2021 | 08:58h | UTC

Brain and other central nervous system tumor statistics, 2021 – CA: A Cancer Journal for Clinicians

 


Randomized phase III trial of prophylactic cranial irradiation with or without hippocampal avoidance for small-cell lung cancer – “This trial provides the first clinical evidence that sparing the hippocampus during PCI in patients with SCLC better preserves cognitive function”.

13 Aug, 2021 | 08:54h | UTC

Randomized Phase III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small-Cell Lung Cancer (PREMER): A GICOR-GOECP-SEOR Study – Journal of Clinical Oncology

 


EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumors.

11 Aug, 2021 | 08:29h | UTC

EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours – Annals of Oncology

Commentary: New guidelines for the diagnosis and treatment of brain metastases – University of Vienna

 

Commentary on Twitter

 


Diagnosing and treating brain tumors: reflections on the latest Cochrane evidence

19 Mar, 2021 | 08:06h | UTC

Diagnosing and treating brain tumours: reflections on the latest Cochrane evidence – Evidently Cochrane

 


Guidelines in the management of CNS tumors

23 Feb, 2021 | 01:09h | UTC

Guidelines in the management of CNS tumors – Journal of Neuro-Oncology

 


Intraoperative imaging technology to maximize extent of resection for glioma: a network meta‐analysis

8 Feb, 2021 | 20:11h | UTC

Intraoperative imaging technology to maximise extent of resection for glioma: a network meta‐analysis – Cochrane Library

 


Stay Updated in Your Specialty

No spam, just news.